July 14, 2014 5:02 AM ET


Company Overview of Vitreoretinal Technologies, Inc.

Company Overview

Vitreoretinal Technologies, Inc., an ophthalmic biopharmaceutical company, engages in the development and commercialization of therapeutic compounds for the treatment of ophthalmic diseases. The company focuses on vitreoretinal ophthalmic diseases and complications related to ophthalmic surgery. Its products include Vitreosolve, a drug used for the treatment of diabetic retinopathy, as well as to liquefy the vitreous gel prior to vitrectomy surgery; and Neurosolve, a compound used for glaucomatous optic nerve damage progression prevention, dry age related macular degeneration progression, and retinitis pigmentosa treatment. VitreoRetinal Technologies Inc. was founded in 1999 and is based in ...

2 Venture

Suite 430

Irvine, CA 92618

United States

Founded in 1999





Key Executives for Vitreoretinal Technologies, Inc.

Chief Operating Officer and Director
Senior Director of Clinical Affairs
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Wyeth Laboratories Inc. United States
Celeres Pharmaceuticals, Inc. United States
Pennino Corporation United States
Active Organics Inc. United States
Ceptaris Therapeutics Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Vitreoretinal Technologies, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.